SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-16-044125
Filing Date
2016-03-01
Accepted
2016-03-01 16:08:04
Documents
1
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2972
  Complete submission text file 0001127602-16-044125.txt   4355
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 EUROPA DRIVE STE 170 CHAPEL HILL NC 27514
Business Address
SANDERS CHARLES A (Reporting) CIK: 0001022936 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 161473272